Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · IEX Real-Time Price · USD

4.300

-0.240 (-5.29%)

At close: Apr 24, 2024, 4:00 PM

4.400

+0.100 (2.33%)

Pre-market: Apr 25, 2024, 8:00 AM EDT

Fate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Cash & Equivalents	57.05	76.56	148.81	182.57	100.04	190.74	89.07	88.73	64.93	49.22	Upgrade
Short-Term Investments	273.31	374.89	482.33	315.57	121.61	10.49	12	3.5	0	0	Upgrade
Cash & Cash Equivalents	330.35	451.45	631.14	498.14	221.65	201.23	101.07	92.23	64.93	49.22	Upgrade
Cash Growth	-26.82%	-28.47%	26.70%	124.74%	10.15%	99.10%	9.58%	42.05%	31.91%	-9.11%	Upgrade
Receivables	1.83	38.48	8.68	5.52	0	0.5	0	0	0	0	Upgrade
Other Current Assets	-0.64	12.14	-6.4	-9.34	5.44	3.46	1.53	1.09	0.72	0.64	Upgrade
Total Current Assets	331.54	502.07	633.41	494.32	227.09	205.2	102.6	93.32	65.65	49.86	Upgrade
Property, Plant & Equipment	158.51	176.09	162.25	99.39	34.17	5.13	2.55	1.58	2.16	1.2	Upgrade
Long-Term Investments	0.98	4.94	100.66	0	39.44	0	0	0	0	0	Upgrade
Other Long-Term Assets	15.19	22.46	25.13	28.74	1.57	2.71	0.15	0.15	0.15	0.12	Upgrade
Total Long-Term Assets	174.68	203.49	288.04	128.13	75.19	7.84	2.7	1.73	2.31	1.32	Upgrade
Total Assets	506.22	705.56	921.46	622.46	302.27	213.03	105.29	95.05	67.96	51.18	Upgrade
Accounts Payable	4.72	8.27	8.61	6.28	5.82	4.21	1.68	0.93	1	0.65	Upgrade
Deferred Revenue	0.69	42.23	48.61	67.17	6.56	15.09	2.83	4.93	7.34	0	Upgrade
Current Debt	6.18	5.63	5.58	3.36	1.69	2.44	0	8.19	7.55	1.54	Upgrade
Other Current Liabilities	27.51	57.93	18.49	8.76	13.73	5.53	6.54	1.13	-2.44	2.39	Upgrade
Total Current Liabilities	39.09	114.05	81.28	85.56	27.81	27.26	11.05	15.19	13.44	4.57	Upgrade
Long-Term Debt	97.36	103.71	109.24	93.94	25.24	12.45	14.81	2.5	10.69	18.07	Upgrade
Other Long-Term Liabilities	1.35	3.86	52.09	58.51	4.48	12.85	2.25	4.21	5.79	0.2	Upgrade
Total Long-Term Liabilities	98.71	107.57	161.33	152.45	29.71	25.3	17.05	6.71	16.48	18.27	Upgrade
Total Liabilities	137.8	221.62	242.62	238.01	57.52	52.56	28.1	21.89	29.92	22.84	Upgrade
Total Debt	103.54	109.34	114.82	97.3	26.93	14.88	14.81	10.69	18.24	19.61	Upgrade
Debt Growth	-5.31%	-4.77%	18.01%	261.34%	80.91%	0.51%	38.55%	-41.40%	-6.99%	1032.10%	Upgrade
Retained Earnings	-1,211.73	-1,050.8	-769.08	-556.93	-383.55	-285.4	-218.8	-175.85	-142.38	-112.39	Upgrade
Comprehensive Income	0.02	-1.85	-0.76	0.07	0.02	-0	-0	-0	0	0	Upgrade
Shareholders' Equity	368.42	483.94	678.84	384.45	244.76	160.47	77.19	73.15	38.04	28.34	Upgrade
Net Cash / Debt	226.82	342.12	516.32	400.85	194.73	186.35	86.26	81.55	46.69	29.62	Upgrade
Net Cash / Debt Growth	-33.70%	-33.74%	28.81%	105.85%	4.50%	116.03%	5.78%	74.64%	57.67%	-43.51%	Upgrade
Net Cash Per Share	2.30	3.53	5.45	4.87	2.86	3.32	2.05	2.57	1.83	1.45	Upgrade
Working Capital	292.45	388.02	552.13	408.76	199.28	177.93	91.55	78.14	52.21	45.29	Upgrade
Book Value Per Share	3.74	5.00	7.17	4.67	3.59	2.86	1.84	2.30	1.49	1.39	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).